Home

Psyence Biomedical Ltd. - Ordinary Shares (PBM)

1.5700
-0.0500 (-3.09%)

Psyence Biomedical Ltd. is a leading biotechnology company focused on harnessing the therapeutic potential of psychedelics to develop innovative treatments for mental health conditions and other ailments

The company is dedicated to conducting research and clinical trials to better understand the efficacy and safety of its psychedelic compounds, aiming to advance the field of mental health care. Through the development of proprietary formulations and treatment protocols, Psyence strives to create evidence-based solutions that can improve the quality of life for patients suffering from conditions such as depression, anxiety, and post-traumatic stress disorder.

SummaryNewsPress ReleasesChartHistoricalFAQ

Frequently Asked Questions

Is Psyence Biomedical Ltd. - Ordinary Shares publicly traded?
Yes, Psyence Biomedical Ltd. - Ordinary Shares is publicly traded.
What exchange does Psyence Biomedical Ltd. - Ordinary Shares trade on?
Psyence Biomedical Ltd. - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Psyence Biomedical Ltd. - Ordinary Shares?
The ticker symbol for Psyence Biomedical Ltd. - Ordinary Shares is PBM on the Nasdaq Stock Market
What is the current price of Psyence Biomedical Ltd. - Ordinary Shares?
The current price of Psyence Biomedical Ltd. - Ordinary Shares is 1.570
When was Psyence Biomedical Ltd. - Ordinary Shares last traded?
The last trade of Psyence Biomedical Ltd. - Ordinary Shares was at 4:00 pm EST on January 31st, 2025